LDH serves as a biomarker in oncology due to its role in anaerobic metabolism, which is often upregulated in cancer cells. Known as the Warburg effect, cancer cells predominantly rely on glycolysis even in the presence of oxygen, leading to increased lactate production and elevated LDH levels. Monitoring LDH can thus provide insights into tumor burden, treatment response, and overall prognosis.
